Literature DB >> 7014612

Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.

S G Amyes.   

Abstract

It is impossible to test accurately bacterial susceptibility to the trimethoprim-sulfamethoxazole combination co-trimoxazole with a single combined susceptibility disk. However, a variety of factors still affect the result even when separate trimethoprim and sulfamethoxazole disks are used. Experiments with separate disks showed that the optimum conditions for testing the susceptibilities of enterobacteria to these drugs were to flood-seed an agar plate with an inoculum of 10(4) to 10(5) organisms per ml, take off the excess liquid, and place a disk of 1 microgram of trimethoprim and another of 50 micrograms of sulfamethoxazole on the surface of the agar with their centers exactly 25 mm apart. This method not only allowed the determination of resistance but also distinguished synergy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014612      PMCID: PMC273846          DOI: 10.1128/jcm.13.4.613-617.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

2.  Practical aspects of testing sensitivity to trimethoprim and sulphonamide.

Authors:  P M Waterworth
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

3.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

4.  Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.

Authors:  S R Bushby
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

5.  The relation of resistance transfer factors to the F-factor (sex-factor) of Escherichia coli K12.

Authors:  E Meynell; N Datta
Journal:  Genet Res       Date:  1966-02       Impact factor: 1.588

6.  Trimethoprim antagonists: effect of uridine in laboratory media.

Authors:  S G Amyes; J T Smith
Journal:  J Antimicrob Chemother       Date:  1978-09       Impact factor: 5.790

7.  Trimethoprim-sensitivity testing and thymineless mutants.

Authors:  S G Amyes; J T Smith
Journal:  J Med Microbiol       Date:  1974-05       Impact factor: 2.472

8.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11

9.  Trimethoprim: laboratory and clinical studies.

Authors:  J H Darrell; L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

10.  Comparison of trimethoprim alone with trimethoprim sulphamethoxazole in the treatment of respiratory and urinary infections with particular reference to selection of trimethoprim resistance.

Authors:  R W Lacey; V L Lord; H K Gunasekera; P J Leiberman; D E Luxton
Journal:  Lancet       Date:  1980-06-14       Impact factor: 79.321

View more
  1 in total

1.  Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.

Authors:  S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.